IHM leads Eurosurveillance publication of an EMGM study group on the epidemiology of serogroup W meningococci15.04.2019
Meningococci cause life-threatening disease primarily in infants and adolescnets. While the incidence of infections has declined over the past 15 years in Europe, the recent emergance of a new serogroup W clone in some European countries caused concerns and gave rise to modifications of vaccine schedules in the UK and the Netherlands.
IHM lead a recent pulication in Eurosurveillance, which described the trends of serogroup W meningococcal disease in 13 European countries from 2013 through 2017. The analysis revealed increasing trends in severeal European countries within the five-years observation period. The major proportion of the increase is attributable to serogroup W meningococci of the clonal complex 11. The publication for the first time provides a comprehensive view for Europe.
31-yr old Manuel Krone is corresponding author of the study. He works at the reference centre for meningococci and Haemophilus influenzae, which is located at the IHM.
The study was an activity of the EMGM society. EMGM promotes collaboration of European reference laboratories and epidemiologists (www.emgm.eu; https://twitter.com/EmgmSociety?lang=en). Ulrich Vogel from IHM is its current president and one of the senior authors of the study.
Krone Manuel, Gray Steve, Abad Raquel, Skoczyńska Anna, Stefanelli Paola, van der Ende Arie, Tzanakaki Georgina, Mölling Paula, João Simões Maria, Křížová Pavla, Emonet Stéphane, Caugant Dominique A., Toropainen Maija, Vazquez Julio, Waśko Izabela, Knol Mirjam J., Jacobsson Susanne, Rodrigues Bettencourt Célia, Musilek Martin, Born Rita, Vogel Ulrich, Borrow Ray. Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017. Euro Surveill. 2019;24(14):pii=1800245. https://doi.org/10.2807/1560-7917.ES.2019.24.14.1800245